Σύγκριση μεθόδων

	Δείκτης Harvey-Bradshaw	Δείκτης Ενεργότητας Νόσου του Crohn
Πεδίο	Γαστρεντερολογία	Γαστρεντερολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1980	1976
Δημιουργός	R. F. Harvey and J. M. Bradshaw	Best, W. R., Becktel, J. M., Singleton, J. W., and Kern, F.
Τύπος	Clinician-rated	Clinician-rated
Θεμελιώδης πηγή	Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514.	Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976). Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology, 70(3), 439–444.
Εναλλακτικές ονομασίες	HBI	CDAI
Συναφείς	5	4
Σύνοψη	The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response.	The Crohn's Disease Activity Index (CDAI) is a comprehensive, weighted index for assessing disease activity in Crohn's disease. Developed in 1976 by Best and colleagues for the National Cooperative Crohn's Disease Study, the CDAI integrates eight clinical and laboratory variables into a single score ranging from <150 (remission) to >450 (severe activity). Although more complex than symptom-based tools, the CDAI captures the multidimensional nature of Crohn's disease and remains the reference standard for severe disease assessment.